Cormorant Global Healthcare Master Fund, LP → Biomea Fusion, Inc. BMEA

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 20/100

Passive Schedule 13G filer baseline
Held by 1 tracked 13F institutional manager
Moderate short days-to-cover (4.8 DTC)
Short interest building (+11.6% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 4.84

15,713,730 shares short · +11.6% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $21K

Point72 Asset Mgmt

Other 13D/G Filings on Biomea Fusion, Inc.

Filed	Form	Filer	Stake	Shares
2025-10-10	SCHEDULE	Cormorant Asset Management, LP	5.31%	3,681,664	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →